Steroids in Duchenne muscular dystrophy.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Neuromuscular Disorders

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.nmd.2013.06.373PMID 23856079
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Steroids in Duchenne dystrophy.

  2013cited by this paper
• Steroids in Duchenne dystrophy.

  2013cited by this paper
• Growth hormone treatment in boys with Duchenne muscular dystrophy and glucocorticoid-induced growth failure.

  2012cited by this paper
• Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy

  2012cited by this paper
• The 6‐minute walk test in Duchenne/Becker muscular dystrophy: Longitudinal observations

  2010cited by this paper
• Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade.

  2006cited by this paper
• Relation between height and clinical course in Duchenne muscular dystrophy.

  1988cited by this paper
• Benign Duchenne muscular dystrophy in a patient with growth hormone deficiency: a five years follow-up.

  1986cited by this paper

• Age, corticosteroid treatment and site of mutations affect motor functional changes in young boys with Duchenne Muscular Dystrophy

  2022cites this paper
• Beneficial Role of Exercise in the Modulation of mdx Muscle Plastic Remodeling and Oxidative Stress

  2021cites this paper
• Pediatric Pulmonology

  2020cites this paper
• Clinical practice with steroid therapy for Duchenne muscular dystrophy: An expert survey in Asia and Oceania.

  2020cites this paper
• Longitudinal natural history in young boys with Duchenne muscular dystrophy.

  2019cites this paper
• Nanotherapy for Duchenne muscular dystrophy.

  2018cites this paper
• The Therapeutic Implications of Muscular Dystrophy Genomics

  2017cites this paper
• Treating Duchenne Cardiomyopathy in the Mouse Model by Gene Repair

  2017cites this paper
• Evolving natural history in Duchenne muscular dystrophy : implications for standard of care and experimental therapies

  2016cites this paper
• Impact of a Comparative Study on the Management of Scoliosis in Duchenne Muscular Dystrophy: Are Corticosteroids Decreasing the Rate of Scoliosis Surgery in the United States?

  2016cites this paper
• Metabolomics Reveals a Key Role for Fumarate in Mediating the Effects of NADPH Oxidase 4 in Diabetic Kidney Disease.

  2016cites this paper
• Improving clinical trial design for Duchenne muscular dystrophy

  2015cites this paper
• Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study

  2015cites this paper
• Corticosteroid Treatment Impact on Spinal Deformity in Duchenne Muscular Dystrophy

  2014cites this paper
• Treatment of dystrophin cardiomyopathies

  2014cites this paper
• Steroids in Duchenne dystrophy.

  2013cites this paper
• Response.

  2013cites this paper
• Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy

  2011cites this paper